Other Briefings
M&A Due Diligence in India: Assessing Target Company Non-Compliance
We examine non-compliance actions that may be identified during the dealmaking process in India and their implications for foreign investors.
India’s Food Labeling Regulations: FSSAI Sets July 1 as Annual Compliance Date
The Food Safety and Standards Authority of India (FSSAI) has set July 1 as the annual date for enforcing any amendments to the food labeling regulations.
BIS Certification in India: A Brief Primer
BIS certification ensures product quality, safety, and compliance with Indian standards. Learn about mandatory and voluntary certification schemes, including ISI, CRS, and hallmarking, for manufacturers, importers, and retailers.
An Introduction to Doing Business in India 2025 – New Publication Out Now
The 2025 edition of ‘An Introduction to Doing Business in India’ provides valuable insights for businesses navigating India’s dynamic market, and covers macroeconomic as well as technical considerations like company setup, tax and audit, HR and payroll.
Corporate Social Responsibility in India
India became one of the first countries to mandate corporate social responsibility (CSR) on April 1, 2014. Certain companies are required to allocate a portion of their profits to areas such as education, poverty alleviation, gender equality, and hunger mitigation programs. We discuss corporate spending trends and compliance requirements under India’s CSR regime.
India’s Draft DPDP Rules, 2025 Released for Public Review
India has released the much awaited draft Digital Personal Data Protection Rules (DPDP Rules), 2025, providing detailed guidelines on notice requirements, consent management, security safeguards, and handling personal data breaches, among other provisions. All stakeholders are advised to read the fine print and prepare for compliance in advance. The draft is open for public review till February 18, 2025.
Pharmaceutical SMEs in India Gain Time to Meet Enhanced GMP Standards Under Revised Schedule M
India’s Union Ministry of Health and Family Welfare has extended the deadline for small- and medium-sized pharmaceutical companies to comply with revised GMP compliance under Schedule M to December 31, 2025, following industry appeals.
SEBI Unveils Integrated Filing Framework for Listed Entities, Mandates Secretarial Audits
SEBI has updated the Listing Obligations and Disclosure Requirements (LODR) regulations with an integrated filing framework, streamlining compliance and disclosures, effective December 31, 2024
